Decision Algorithm for Vital Sign Assessment in the Outpatient Physical Therapy Setting
Public ClinicalTrials.gov record NCT07258030. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Development of a Decision Algorithm for Vital Sign Assessment in the Outpatient Physical Therapy Setting: An e-Delphi Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Brief Summary The goal of this observational study is to develop consensus-based criteria for when vital sign assessment (VSA) should be performed in outpatient physical therapy settings. The primary purpose is to identify clinical signs, symptoms, and other factors that inform decision-making for VSA to improve patient safety and guide treatment progression. Main Questions: 1. Which clinical characteristics indicate that vital signs should be assessed during outpatient physical therapy? 2. Which clinical characteristics indicate that vital signs do not need to be assessed? Study Design: This study uses a three-round electronic Delphi (e-Delphi) process to achieve expert consensus. Comparison: Researchers will compare responses across rounds to determine agreement and stability of criteria for inclusion in a decision algorithm. Participants: Licensed physical therapists with ≥5 years of clinical experience in outpatient settings. Procedures: Participants will: Complete three rounds of online surveys via Qualtrics. Round 1: Suggest signs, symptoms, and factors for assessing or not assessing vitals. Round 2: Rank importance of these factors on a 5-point Likert scale and suggest additional items. Round 3: Review aggregated results and finalize consensus on criteria.
Study identification
- NCT ID
- NCT07258030
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 100 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 21, 2025 (Estimated)
- Primary completion
- Mar 31, 2026 (Estimated)
- Completion
- Apr 2026 (Estimated)
- Last update posted
- Dec 2, 2025
2025 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Youngstown State University | Youngstown | Ohio | 44555 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07258030, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 2, 2025 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07258030 live on ClinicalTrials.gov.